392
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome

, , &
Pages 885-889 | Received 31 Mar 2014, Accepted 08 Jul 2014, Published online: 29 Aug 2014
 

Abstract

Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age with anti-müllerian hormone (AMH) two to three times higher, but the mechanism of increased AMH, excessive follicles and follicle stagnation in PCOS still needs further research.

Methods: Female Sprague–Dawley rats were treated with a gavage of 1.0 mg/kg of letrozole carboxymethylcellulose solution once daily for 21 consecutive days. Serum steroid concentrations, ovarian morphology, ovarian expression of AMH and AMH-RII protein were determined and their relationships were studied.

Results: According to the morphology and endocrinology, the letrozole model group was a successful PCOS model. Serum AMH and ovarian local expression of AMH and AMH-RII were both increased in letrozole model group. The elevated AMH had a positive correlation with T, growing follicle count and a negative correlation with body weight.

Conclusions: The letrozole model group is a good animal model for the study of AMH in PCOS patients with obesity or insulin resistance. The increased serum AMH level in PCOS is the consequence of the androgen-induced excess of small antral follicles. These results lead to the hypothesis that reducing AMH may become a therapeutic target of PCOS, which is worth further research.

Chinese abstract

多囊卵巢综合征(PCOS)是育龄期女性常见的内分泌疾病,其抗苗勒管激素(AMH)升高两到三倍,但PCOS的高AMH水平、卵泡过多和停滞发育的机制仍需要进一步的研究。雌性SD大鼠用来曲唑羧甲基纤维素钠溶液灌胃,1毫克/公斤,每日一次,连续21天。测定血清类固醇的浓度,卵巢形态,卵巢AMH和AMH-RⅡ蛋白质表达,研究了其相互关系。根据形态和内分泌,来曲唑组是一个成功的PCOS模型。血清AMH及卵巢局部AMH和AMH-RⅡ蛋白质表达都在来曲唑模型组上升。AMH上升与T、生长卵泡数呈正相关,与体重呈负相关。来曲唑模型是研究肥胖或胰岛素抵抗PCOS患者的AMH的一种好的动物模型。PCOS血清AMH上升是雄激素引起的小窦卵泡过多的结果。这些结果提示,降低AMH可能成为多囊卵巢综合征的治疗目标,值得进一步研究。

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.